Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

KRAS G12D targeted therapies for pancreatic cancer: Has the fortress been conquered?
Sahar F. Bannoura, Husain Yar Khan, Asfar S. Azmi
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 61

Showing 26-50 of 61 citing articles:

Graph Attention Networks for Drug Combination Discovery: Targeting Pancreatic Cancer Genes with RAIN Protocol
Elham Parichehreh, Ali Akbar Kiaei, Mahnaz Boush, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Molecular Classification and Pathogenesis of Pancreatic Adenocarcinoma and Targeted Therapies: A Review
Samantha M. Ruff, Timothy M. Pawlik
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 3
Open Access | Times Cited: 2
Design, synthesis, and evaluation of purine and pyrimidine-based KRAS G12D inhibitors: Towards potential anticancer therapy
S.L. Park, Venu Venkatarame Gowda Saralamma, Sagar D. Nale, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e28495-e28495
Open Access | Times Cited: 2
Targeted Therapies in Pancreatic Cancer: A New Era of Precision Medicine
Bingyu Li, Qiong Zhang, Claire Castaneda, et al.
Biomedicines (2024) Vol. 12, Iss. 10, pp. 2175-2175
Open Access | Times Cited: 2
KRAS mutations in endometrial cancers: Possible prognostic and treatment implications
Karolina A. Kilowski, Martin Dietrich, Joanne Xiu, et al.
Gynecologic Oncology (2024) Vol. 191, pp. 299-306
Open Access | Times Cited: 2
Cholesterol metabolism in pancreatic cancer and associated therapeutic strategies
Tasvi Daya, Andrea Breytenbach, Liang Gu, et al.
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2024) Vol. 1870, Iss. 2, pp. 159578-159578
Open Access | Times Cited: 2
A case of adenosquamous pancreatic cancer with a KRAS G12C mutation with an exceptional response to immunotherapy
Murtaza Ahmed, Brent K. Larson, Arsen Osipov, et al.
Oncotarget (2024) Vol. 15, Iss. 1, pp. 741-747
Open Access | Times Cited: 1
Structure-Based Design and Synthesis of Potent and Selective KRAS G12D Inhibitors
Hengmiao Cheng, Puhui Li, Ping Chen, et al.
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 10, pp. 1351-1357
Closed Access | Times Cited: 4
Combination of mutations in genes controlling DNA repair and high mutational load plays a prognostic role in pancreatic ductal adenocarcinoma (PDAC): a retrospective real-life study in Sardinian population
Maria Cristina Sini, Maria Grazia Doro, Laura Frogheri, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Abnormalities in the KRAS Gene and Treatment Options for NSCLC Patients with the G12C Mutation in This Gene—A Literature Review and Single-Center Experience
Anna K. Rekowska, Piotr Rola, Agnieszka Kwiatkowska, et al.
Biomedicines (2024) Vol. 12, Iss. 2, pp. 325-325
Open Access | Times Cited: 1
pH-responsive targeted nanoparticles release ERK-inhibitor in the hypoxic zone and sensitize free gemcitabine in mutant K-Ras-addicted pancreatic cancer cells and mouse model
Debasmita Dutta, Priyanka Ray, Archana De, et al.
PLoS ONE (2024) Vol. 19, Iss. 4, pp. e0297749-e0297749
Open Access | Times Cited: 1
radioGWAS links radiome to genome to discover driver genes with somatic mutations for heterogeneous tumor image phenotype in pancreatic cancer
Dandan Zheng, Paul M. Grandgenett, Qi Zhang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Semaphorin 3D promotes pancreatic ductal adenocarcinoma progression and metastasis through macrophage reprogramming
Noelle R. J. Thielman, Vanessa Funes, Sanjana Davuluri, et al.
Science Advances (2024) Vol. 10, Iss. 42
Open Access | Times Cited: 1
An Atypical Case of Pancreatic Cancer with Mesenchymal Differentiation in a Patient with Primary Lung Adenocarcinoma: Insights into Tumor Biology and Novel Therapeutic Pathways
Noura Abbas, Lama Zahreddine, Ayman Tawil, et al.
Diagnostics (2024) Vol. 14, Iss. 22, pp. 2512-2512
Open Access | Times Cited: 1
Genome-wide CRISPR Screen Reveals RAB10 as a Synthetic Lethal Gene in Colorectal and Pancreatic Cancers Carrying SMAD4 Loss
Hélène Erasimus, Vanessa Kolnik, Frédéric Lacroix, et al.
Cancer Research Communications (2023) Vol. 3, Iss. 5, pp. 780-792
Open Access | Times Cited: 3
Repositioning of Montelukast to inhibit proliferation of mutated KRAS pancreatic cancer through a novel mechanism that interfere the binding between KRAS and GTP/GDP
Yannan Xia, Shujie Zhang, Hongyi Luo, et al.
European Journal of Pharmacology (2023) Vol. 961, pp. 176157-176157
Closed Access | Times Cited: 3
Discovery of Potent Deuterated Compounds as Potential KRASG12D Inhibitors in Cancer Therapy
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 4, pp. 362-364
Open Access | Times Cited: 2
Targeted Degradation of KRASG12D as Potential Therapy in Cancer
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 5, pp. 537-538
Open Access | Times Cited: 2
Targeting KRASG12D Mutations: Discovery of Small Molecule Inhibitors for the Potential Treatment of Intractable Cancers
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 8, pp. 1041-1042
Closed Access | Times Cited: 2
Combined PI3K and MAPK inhibition synergizes to suppress PDAC
Bailey A. Bye, Jarrid Jack, Alexandra Pierce, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Tumor- and Nerve-Derived Axon Guidance Molecule Promotes Pancreatic Ductal Adenocarcinoma Progression and Metastasis through Macrophage Reprogramming
Noelle R. J. Thielman, Vanessa Funes, Sanjana Davuluri, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Combination of mutations in genes controlling DNA repair and high mutational load plays a prognostic role in pancreatic ductal adenocarcinoma (PDAC): a retrospective real-life study in Sardinian population
Maria Cristina Sini, MariaGrazia Doro, Laura Frogheri, et al.
Research Square (Research Square) (2024)
Open Access
A Recent Overview of the Growing Applications of Biosimilars in Pancreatic Cancer Management: Current Picture and Future Perspectives
Dhruv Gupta, Daksh Sanjay Gupta, Saritha Shetty
(2024), pp. 157-175
Closed Access
Genetics and biology of pancreatic ductal adenocarcinoma
Maung Jai, Paul Mozdziak
Medical Journal of Cell Biology (2024) Vol. 12, Iss. 2, pp. 42-47
Open Access
Treatments Relevant to Individual Cancer Types

(2024), pp. 359-410
Closed Access

Scroll to top